9-aminocamptothecin has been researched along with Colonic Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, JC; Caranfa, MJ; Faucette, LF; Gallagher, G; Hecht, SM; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; McCabe, FL | 1 |
| Burnouf, PA; Chen, KC; Cheng, TL; Chou, HC; Huang, PT; Leu, YL; Prijovich, ZM; Roffler, SR | 1 |
| Gao, SQ; Kopecek, J; Kopecková, P; Peterson, CM; Sun, Y | 1 |
| Egorin, MJ; Eiseman, JL; Hamburger, DR; Jin, R; Joseph, E; Jung, LL; Ramanathan, RK; Strychor, S; Zamboni, WC | 1 |
| Giovanella, BC | 1 |
| Willson, JK | 1 |
| Firby, PS; Horn, L; Li, ML; Moore, MJ | 1 |
1 review(s) available for 9-aminocamptothecin and Colonic Neoplasms
| Article | Year |
|---|---|
Topoisomerase-I inhibitors in the management of colon cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Colonic Neoplasms; Enzyme Inhibitors; Humans; Irinotecan; Topoisomerase I Inhibitors; Topotecan | 1996 |
7 other study(ies) available for 9-aminocamptothecin and Colonic Neoplasms
| Article | Year |
|---|---|
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Colonic Neoplasms; DNA, Superhelical; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Structure; Plasmids; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1991 |
Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Female; Glucuronidase; Glucuronides; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Prodrugs; Topotecan | 2016 |
Antitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Female; Humans; Male; Materials Testing; Methacrylates; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Polymers; Survival Rate; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2009 |
Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Camptothecin; Cell Line, Tumor; Chromatography, High Pressure Liquid; Colonic Neoplasms; Female; HT29 Cells; Humans; Mice; Mice, SCID; Treatment Outcome; Xenograft Model Antitumor Assays | 2005 |
Clinical trials referral resource. Clinical trials with 9-aminocamptothecin.
Topics: Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Colonic Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neutropenia | 1995 |
New perspectives in colon cancer chemotherapy.
Topics: Animals; Camptothecin; Colonic Neoplasms; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation | 1994 |
Pharmacological determinants of 9-aminocamptothecin cytotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Camptothecin; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2001 |